Glorian Sorensen PhD, MPH (DFCI) was recently awarded $200,000 from the National Cancer Institute (NCI) to promote research collaborations with institutions in low-... | [more]
Welcome to Dana-Farber/Harvard Cancer CenterDana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.
Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.
- The DF/HCC High-Throughput Polymorphism Detection Core adds targeted sequencing service Posted: 07-16-14
- Cancer Research Network Scholars Program: Call for Applications Posted: 07-16-14
- NCCN Request for Proposals (RFP): Phase I/II Clinical Trials and Pre-Clinical Trials of Enzalutamide for Selected Cancers Posted: 07-01-14
Latest Cancer News
UMass Boston and DF/HCC have a U54 Partnership grant with NCI/CRCHD to develop life sciences and CPCT on the UMass Boston campus. Read the Spotlight: ... | [more]
April 14, 2014 Congratulations to Levi Garraway and Rakesh Jain, who were among the 2014 American Association for Cancer Research (AACR) awardees: Levi Garraway (DFCI) was... | [more]